Search Within

Matthew D Keller

Formats
  1. Journal Article (13)
  2. Meeting Abstract (12)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (26)
  2. Center for Hematologic Malignancies (26)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (26)
  4. Department of Medicine (26)
  5. Executive Committee, Center for Hematologic Malignancies (26)
  6. GSK Faculty (26)

More Groups

People
  1. Ross Levine (26)
  2. Maria Kleppe (17)
  3. Franck Rapaport (9)
  4. Kaitlyn Shank (9)
  5. Lennart Bastian (8)
  6. Neha Bhagwat (8)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (2)
  4. 2017 (2)
  5. 2016 (4)
  6. 2015 (7)

More Years

Publications
  1. Blood (8)
  2. Haematologica (3)
  3. Nature Medicine (3)
  4. Cancer Cell (2)
  5. Cancer Research (2)
  6. Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Nature Publishing Group (6)
  3. American Association for Cancer Research (3)
  4. Cell Press (3)
  5. Ferrata Storti Foundation (3)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic studies reveal Jak2 is not essential for platelet production
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Woods, B. A.; LaFave, L. M.; Bastian, L.; Kleppe, M.; Bhagwat, N.; Marubayashi, S.; Levine, R. L.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2
    Journal Article

    Grundschober, E.; Hoelbl-Kovacic, A.; Bhagwat, N.; Kovacic, B.; Scheicher, R.; Eckelhart, E.; Kollmann, K.; Keller, M.; Grebien, F.; Wagner, K. U.; more...
    Leukemia (2014)

    Fulltext@MSK | Save
  • Genetic studies reveal an unexpected negative regulatory role for jak2 in thrombopoiesis
    Journal Article

    Meyer, S. C.; Keller, M. D.; Woods, B. A.; LaFave, L. M.; Bastian, L.; Kleppe, M.; Bhagwat, N.; Marubayashi, S.; Levine, R. L.
    Blood (2014)

    Fulltext@MSK | Save
  • Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms
    Journal Article

    Bhagwat, N.; Koppikar, P.; Keller, M.; Marubayashi, S.; Shank, K.; Rampal, R.; Qi, J.; Kleppe, M.; Patel, H. J.; Shah, S. K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Improved efficacy of combination of JAK2 and Hedgehog inhibitors in myelofibrosis
    Meeting Abstract

    Bhagwat, N.; Keller, M. D.; Rampal, R. K.; Shank, K.; de Stanchina, E.; Rose, K.; Amakye, D.; Levine, R. L.
    Blood (2013)

    Fulltext@MSK | Save
  • Coordinate regulation of chromatin state by JAK2 and ASXL1 mutations in myeloid malignancies
    Meeting Abstract

    LaFave, L. M.; Chung, Y. R.; Keller, M.; Kleppe, M.; Mullally, A.; Abdel-Wahab, O.; Levine, R. L.
    Cancer Research (2013)

    Fulltext@MSK | Save